en · de · es · pt
aod-9604-notes.peptides6608.com › Guide › Identity And Research Context — What the Evidence Shows

Identity And Research Context — What the Evidence Shows

By Editorial Desk · published 2025-09-11 · last reviewed 2025-10-31 · Guide

hGH fragment is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Last reviewed on 2025-10-31. Where a claim depends on a specific study, the study is described rather than over-claimed.

Identity and Research Context

Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.

AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.

Regulatory and Analytical Context

In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.

Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.

Aod-9604 at a glance

PropertyValueNotes
Common nameAOD-9604Development code used in scientific literature.
Chemical classSynthetic peptideFragment of human growth hormone.
Amino acid length16 residuesMatches hGH region 176-191.
AppearanceWhite to off-white powderTypical lyophilized peptide solid.
SolubilitySoluble in waterDissolves in aqueous media; exact behavior depends on salt form.

Background and Development History

Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.

AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.

Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.

Related pages on this site

Identity and Molecular Context

Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.

AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.

The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.

Reference notes

== Treatment == Myxomas are usually removed surgically. The surgeon removes the myxoma, along with at least 5 surrounding millimeters of atrial septum. The septum is then repaired, using material from the pericardium.

Other predicted darmstadtium compounds are darmstadtium carbide (DsC) and darmstadtium tetrachloride (DsCl4), both of which are expected to behave like their lighter homologues platinum carbide and platinum tetrachloride. Unlike platinum, which preferentially forms a cyanide complex in its +2 oxidation state, Pt(CN)2, darmstadtium is expected to preferentially remain in its neutral state and form Ds(CN)2−2 instead, forming a strong Ds–C bond with some multiple bond character.

==== Intracrine function of VEGF in cardiac cells ==== VEGF has been identified as an intracrine factor, meaning that it not only acts through autocrine and paracrine pathways but also functions within the cells that produce it. In cardiac myocytes and endothelial cells, VEGF can be synthesized and retained intracellularly, where it directly influences gene expression, protein synthesis, and cellular survival mechanisms. Unlike its secreted counterpart, intracrine VEGF operates independently of cell-surface receptors, exerting effects within the nucleus and cytoplasm. Studies suggest that intracrine VEGF contributes to cellular differentiation during cardiac organogenesis. In embryonic and progenitor cardiac cells, VEGF facilitates the transcription of genes involved in cell survival, proliferation, and vascular patterning. Its presence in stem cell nuclei suggests that it may regulate ribosomal DNA transcription, similar to other intracrines, thereby coordinating cellular growth and differentiation.

==== Internationals that emerged from the International Committee of the Fourth International (ICFI) ==== International Committee of the Fourth International (WRP), ICFI (1953) International Communist League (Fourth Internationalist), ICL-FI) (1974) previously the international Spartacist tendency which split from the ICFI. International Bolshevik Tendency, IBT (1982) formed by expelled members of the international Spartacist tendency. International Trotskyist Committee, ITC (1984), founded by former members of the defunct Trotskyist International Liaison Committee. The latter was founded by expelled members of the ICFI in 1974. International Committee of the Fourth International (SEP), ICFI (1985) League for the Fourth International, LFI (1998). Organising Committee for the Reconstitution of the Fourth International, OCRFI (2016) Bolshevik Tendency, (2018) split from IBT. Liaison Committee for the Fourth International, founded by former members of the ITC.

The RCMP Security Service (French: Service de sécurité de la GRC) was a branch of the Royal Canadian Mounted Police (RCMP) that had responsibility for domestic intelligence and security in Canada. It was replaced by the Canadian Security Intelligence Service (CSIS) in 1984 on the recommendation of the McDonald Commission, which was called in the wake of major scandals during the 1970s.

Sources: en.wikipedia.org

Reference notes

=== 1973 to 2009 === Hanmi was founded in 1973 by Lim Sung-ki, who was a pharmacist. It was originally named Lim, Sung-ki Pharmaceutical Co., but it was quickly changed to Hanmi Pharmaceutical. The company originally started selling Trimethoprim/sulfamethoxazole powder, and would expand to produce Cephalosporin antibiotics in 1985 and injectable Ceftriaxone antibiotics in 1987. By 1988 the company was listed in the Korea Exchange. Hanmi started selling drugs in China in 1996. In 1994, the company began developing Cyclosporin. The company broke the ₩100,000,000,000 barrier in sales in 1997. The company began moving into the European market in 1998. The company still was developing new drugs, with Paclitaxel in 2000, Itraconazole tablets in 2001, 24-hour controlled-release Nifedipine tablets and a new salt form of Amlodipine in 2004, and an anti-obesity drug using sibutramine mesilate in 2007. Hanmi and Crystal Genomics formed a strategic partnership in 2008.

The council deals with a variety of local issues such as outdoor patio applications, neighbourhood traffic plans, and exemptions from certain by-laws such as retail signs, fences, trees and ravines. Decisions made by community council are approved by Toronto City Council in order to take effect.

July 29: Decree-law on family and French natality. November 29: The conversion of legal separation into divorce sees its delay temporarily reduced to one year during the war (Second World War). November 29: Decree concerning the prevention of venereal diseases. Vichy Regime (July 1940-August 1944) October 11, 1940: Law on women's work — aimed at combating unemployment; notably prohibits the hiring of married women in the administration. 1941

=== 2. Periodontal ligament === The periodontal ligament is a specialized, vascular, and cellular connective tissue occupying the space between the cementum of the tooth root and the alveolar bone socket. It is primarily composed of dense collagen fiber bundles, known as Sharpey's fibers, which anchor the tooth to the surrounding alveolar bone. Functionally, the periodontal ligament acts as a shock absorber during mastication, provides proprioceptive sensory input, and contributes to the nutritional and reparative capacity of the periodontal tissues. In periodontitis, progressive destruction of periodontal ligament fibers occurs in association with apical migration of the junctional epithelium, resulting in increased tooth mobility.

Signs of sickle cell disease usually begin in early childhood. The severity of symptoms can vary from person to person, as can the frequency of crisis events. Sickle cell disease may lead to various acute and chronic complications, several of which have a high mortality rate.

Sources: en.wikipedia.org

Notes from published material

This was partly because Paleolithic hunter-gatherers accessed a wider variety of natural foods, which allowed them a more nutritious diet and a decreased risk of famine. Many of the famines experienced by Neolithic (and some modern) farmers were caused or amplified by their dependence on a small number of crops. It is thought that wild foods can have a significantly different nutritional profile than cultivated foods. The greater amount of meat obtained by hunting big game animals in Paleolithic diets than Neolithic diets may have also allowed Paleolithic hunter-gatherers to enjoy a more nutritious diet than Neolithic agriculturalists. It has been argued that the shift from hunting and gathering to agriculture resulted in an increasing focus on a limited variety of foods, with meat likely taking a back seat to plants. It is also unlikely that Paleolithic hunter-gatherers were affected by modern diseases of affluence such as type 2 diabetes, coronary heart disease, and cerebrovascular disease, because they ate mostly lean meats and plants and frequently engaged in intense physical activity, and because the average lifespan was shorter than the age of common onset of these conditions. Large-seeded legumes were part of the human diet long before the Neolithic Revolution, as evident from archaeobotanical finds from the Mousterian layers of Kebara Cave, in Israel. There is evidence suggesting that Paleolithic societies were gathering wild cereals for food use at least as early as 30,000 years ago.

Interchim is a privately owned French company specialized in manufacturing and distribution of reagents, consumables and dedicated instruments for the R&D and industry laboratory in the fields of fine chemistry, chromatography and bio-analysis. It has become a provider of reference methods, products for analytics (analytical chemistry and bioassays) serving research and quality control in the biomedical field, pharmaceutical industry, but also cosmetics and environment.

=== Cocket bread === Cocket bread was a type of bread in England, as referenced in the Assize of Bread and Ale (temp. incert.) (c. 1266), where it is one of several kinds of bread named. It seems to have been hard sea-biscuit, which perhaps had then some mark or seal (a cocket) on it; or else, was so called from its being designed for the use of the coxswains, or seamen.

Ni(CO)4 ⇌ Ni + 4 CO This behavior is exploited in the Mond process for purifying nickel. The related nickel(0) complex bis(cyclooctadiene)nickel(0) is a useful catalyst in organonickel chemistry because the cyclooctadiene (or cod) ligands are easily displaced.

=== Breeding === In India, from where moringa most likely originated, the diversity of wild types gives a good basis for breeding programs. In countries where moringa has been introduced, the diversity is usually much smaller among the cultivar types. Locally well-adapted wild types, though, can be found in most regions. Because moringa is cultivated and used in different ways, breeding aims for an annual or a perennial plant are obviously different. The yield stability of fruits is an important breeding aim for the commercial cultivation in India, where moringa is cultivated as an annual. On less favorable locations, perennial cultivation has big advantages, such as less erosion. In Pakistan, varieties have been tested for the nutritional composition of their leaves on different locations. India selects for a higher number of pods and dwarf or semidwarf varieties. Breeders in Tanzania, though, are selecting for higher oil content.

Sources: en.wikipedia.org

Frequently asked questions

What is AOD-9604?

AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.

Is AOD-9604 the same as human growth hormone?

No. It contains only a small portion of the human growth hormone sequence. The full hormone has 191 amino acids and many additional actions that the fragment does not share.

Why is it called hGH fragment 176-191?

The name refers to the amino acid positions in the human growth hormone chain. The fragment spans residues 176 through 191 at the C-terminal end. This naming convention helps distinguish it from full-length hGH.

Is AOD-9604 approved for medical use?

No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.

Network